Browse comprehensive healthcare market research reports across all industry segments.
Cryoneurolysis is emerging as a minimally invasive option for chronic pain, offering targeted relief without major surgery or daily medication. By temporarily interrupting nerve pain signals, it may support faster recovery, improved mobility, and better quality of life.
Generic injectable drug shortages are creating growing supply-chain challenges for U.S. hospitals. Supplier concentration, manufacturing disruptions, limited visibility, and low margins are increasing pressure on pharmacy teams and highlighting the need for stronger sourcing & contingency planning.
The global GLP-1 analogues market includes injectable and oral GLP-1 receptor agonists used to treat type 2 diabetes and obesity by improving blood glucose control, promoting weight loss, and reducing cardiovascular risk. Market growth is driven by the rising prevalence of diabetes and obesity, expanding clinical indications, increasing patient and physician awareness, and continuous innovation in GLP-1 therapies.
The next-generation sequencing (NGS) market includes advanced sequencing platforms, instruments, reagents, software, bioinformatics tools, and sequencing services used for rapid DNA and RNA analysis. NGS is widely applied in clinical diagnostics, oncology, infectious disease testing, reproductive genetics, rare disease research, precision medicine, drug discovery, agriculture, and genomics research. Growth is driven by increasing adoption of genomic technologies and personalized medicine.